Vitiligo Associated with Alpha-Interferon in a Patient with Chronic Active Hepatitis C

Keyvan Nouri; Mariano Busso; Brian C. Machler

Vitiligo Associated with Alpha-Interferon in a Patient with Chronic Active Hepatitis C

Keyvan Nouri, Mariano Busso, Brian C. Machler

Dermatology & Cutaneous Surgery

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Abstract

We report a case of vitiligo that occurred during the second month of interferon alpha 2a therapy for chronic active hepatitis C. The patient received the interferon for four months.

Original language	English (US)
Pages (from-to)	289-290
Number of pages	2
Journal	Cutis
Volume	60
Issue number	6
State	Published - Dec 1 1997

ASJC Scopus subject areas

Dermatology

Fingerprint Dive into the research topics of 'Vitiligo Associated with Alpha-Interferon in a Patient with Chronic Active Hepatitis C'. Together they form a unique fingerprint.

Cite this

@article{a50771f99c934f7fb954c38f3c377345,

title = "Vitiligo Associated with Alpha-Interferon in a Patient with Chronic Active Hepatitis C",

abstract = "We report a case of vitiligo that occurred during the second month of interferon alpha 2a therapy for chronic active hepatitis C. The patient received the interferon for four months.",

author = "Keyvan Nouri and Mariano Busso and Machler, {Brian C.}",

year = "1997",

month = dec,

day = "1",

language = "English (US)",

volume = "60",

pages = "289--290",

journal = "Cutis",

issn = "0011-4162",

publisher = "Quadrant Healthcom Inc.",

number = "6",

}

TY - JOUR

T1 - Vitiligo Associated with Alpha-Interferon in a Patient with Chronic Active Hepatitis C

AU - Nouri, Keyvan

AU - Busso, Mariano

AU - Machler, Brian C.

PY - 1997/12/1

Y1 - 1997/12/1

N2 - We report a case of vitiligo that occurred during the second month of interferon alpha 2a therapy for chronic active hepatitis C. The patient received the interferon for four months.

AB - We report a case of vitiligo that occurred during the second month of interferon alpha 2a therapy for chronic active hepatitis C. The patient received the interferon for four months.

UR - http://www.scopus.com/inward/record.url?scp=0031301978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031301978&partnerID=8YFLogxK

M3 - Article

C2 - 9426968

AN - SCOPUS:0031301978

VL - 60

SP - 289

EP - 290

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 6

ER -